Editor's Pick

Xenetic Biosciences, Inc. (NASDAQ: XBIO), a clinical-stage biopharmaceutical company focused on the discovery, research & development of next-generation biologic drugs, announced that it received a $3 million milestone payment from Shire plc (LSE: SHP, NASDAQ:SHPG) related to Shire’s advancing the Phase 1/2a clinical study for the PSA-Recombinant SHP656 or Factor VIII...

Ariad Pharmaceuticals Inc (NASDAQ:ARIA) shares popped up 72.85% to $23.75 on Monday then pulled back 0.04% to $23.74 in after-hours trading. Share prices have been trading in a 52-week range of $4.37 to $23.81 so it's already at the resistance. The company has a market cap of $4.73 billion...

Gevo Inc (NASDAQ:GEVO) shares were up nearly 1% on Monday to $4.09 but retreated 2.69% in after-hours trading to $3.98. The company has a market cap of $11.90 billion at 6.82 million shares outstanding. Share prices have been trading in a 52-week range of $3.20 to $27.20 so there's...

Applied DNA Sciences Inc (NASDAQ:APDN) shares dipped 2.63% on Friday to $1.85 and were flat in after-hours trading. Share prices have been trading in a 52-week range of $1.73 to $3.74. The company has a market cap of $47.47 million at 26.35 million shares outstanding. Applied DNA Sciences Inc is...

Cannabis Science Inc (OTCMKTS:CBIS) shares rose 9.77% on Friday to $0.0657 and retreated 0.61% to $0.0653 in after-hours trading. Share prices have been trading in a 52-week range of $0.01 to $0.08. The company has a market cap of $150.54 million at 2.31 billion shares outstanding. Cannabis Science Inc is a...